Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Vet Dermatol ; 24(3): 323-8, e71-2, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23617395

ABSTRACT

BACKGROUND: Studies comparing the ability of staining methods to detect eosinophils in formalin-fixed canine skin are lacking. HYPOTHESIS/OBJECTIVES: The aim of this study was to compare the effectiveness of eosinophil peroxidase monoclonal antibody (EPXmAb), Luna and haematoxylin and eosin (H&E) to detect eosinophils in fixed canine skin by assessing the following parameters: (i) specificity of eosinophil staining; (ii) extracellular eosinophil granule staining; (iii) tissue background staining; (iv) contrast between eosinophil and surrounding tissue staining; and (v) differences in the number of eosinophils detected by each stain. METHODS: Three serial sections of formalin-fixed, paraffin-embedded tissues of predominantly eosinophilic skin diseases (n = 8), noneosinophilic skin diseases (n = 7) and normal canine skin (n = 1) were stained with the three stains. Each parameter was independently assessed and scored by two investigators. RESULTS: Luna and EPXmAb were specific in detecting eosinophils. The EPXmAb was significantly more effective than Luna (P < 0.001) and H&E (P < 0.001) in its ability to detect extracellular eosinophil granules (i.e. to detect intact and released eosinophil granules). The EPXmAb showed significantly less background staining compared with Luna (P = 0.0005). Moreover, significantly more stain contrast was noted with EPXmAb compared with Luna (P = 0.003) and H&E (P < 0.001). There was no significant difference between the mean eosinophil counts among the three stains. CONCLUSION AND CLINICAL IMPORTANCE: The three stains were shown to be useful to detect and quantify eosinophils in fixed canine skin. The EPXmAb-based immunohistochemical stain proved to be a novel tool to detect eosinophils in canine skin.


Subject(s)
Dogs , Eosinophils/cytology , Hematoxylin/chemistry , Skin/cytology , Staining and Labeling/veterinary , Tissue Fixation/veterinary , Animals , Antibodies, Monoclonal , Coloring Agents/chemistry , Eosinophil Peroxidase/immunology , Formaldehyde , Staining and Labeling/methods , Tissue Fixation/methods
2.
Vet Immunol Immunopathol ; 149(1-2): 136-42, 2012 Sep 15.
Article in English | MEDLINE | ID: mdl-22749291

ABSTRACT

Canine atopic dermatitis (AD) is clinically similar to human AD, implicating it as a useful model of human eosinophilic allergic disease. To identify cutaneous gene transcription changes in relatively early inflammation of canine AD, microarrays were used to monitor transcription in normal skin (n=13) and in acute lesional AD (ALAD) and nearby visibly nonlesional AD (NLAD) skin (n=13) from dogs. Scanning the putative abnormally transcribed genes, several potentially relevant genes, some abnormally transcribed in both NLAD and ALAD (e.g. IL6, NFAM1, MSRA, and SYK), were observed. Comparison for abnormally transcribed genes common to two related human diseases, human AD and asthmatic chronic rhinosinusitis with nasal polyps (aCRSwNP), further identified genes or gene sets likely relevant to eosinophilic allergic inflammation. These included: (1) genes associated with alternatively activated monocyte-derived cells, including members of the monocyte chemotactic protein (MCP) gene cluster, (2) members of the IL1 family gene cluster, (3) eosinophil-associated seven transmembrane receptor EMR1 and EMR3 genes, (4) interferon-inducible genes, and (5) keratin genes associated with hair and nail formation. Overall, numerous abnormally transcribed genes were observed only in canine AD; however, many others are common to related human eosinophilic allergic diseases and represent therapeutic targets testable in dogs with AD.


Subject(s)
Dermatitis, Atopic/veterinary , Dog Diseases/genetics , Dog Diseases/immunology , Eosinophilia/genetics , Eosinophilia/immunology , Animals , Biopsy/veterinary , Dermatitis, Atopic/genetics , Dermatitis, Atopic/immunology , Dogs , Gene Expression Profiling/veterinary , Humans , Oligonucleotide Array Sequence Analysis/veterinary , RNA/chemistry , RNA/genetics , Transcription, Genetic
3.
PLoS One ; 5(7): e11450, 2010 Jul 06.
Article in English | MEDLINE | ID: mdl-20625511

ABSTRACT

BACKGROUND: Asthmatic chronic rhinosinusitis with nasal polyps (aCRSwNP) is a common disruptive eosinophilic disease without effective medical treatment. Therefore, we sought to identify gene expression changes, particularly those occurring early, in aCRSwNP. To highlight expression changes associated with eosinophilic epithelial inflammation, we further compared the changes in aCRSwNP with those in a second eosinophilic epithelial disease, atopic dermatitis (AD), which is also closely related to asthma. METHODS/PRINCIPAL FINDINGS: Genome-wide mRNA levels measured by exon array in both nasosinus inflamed mucosa and adjacent polyp from 11 aCRSwNP patients were compared to those in nasosinus tissue from 17 normal or rhinitis subjects without polyps. Differential expression of selected genes was confirmed by qRT-PCR or immunoassay, and transcription changes common to AD were identified. Comparison of aCRSwNP inflamed mucosa and polyp to normal/rhinitis tissue identified 447 differentially transcribed genes at > or = 2 fold-change and adjusted p-value < 0.05. These included increased transcription of chemokines localized to chromosome 17q11.2 (CCL13, CCL2, CCL8, and CCL11) that favor eosinophil and monocyte chemotaxis and chemokines (CCL18, CCL22, and CXCL13) that alternatively-activated monocyte-derived cells have been shown to produce. Additional transcription changes likely associated with Th2-like eosinophilic inflammation were prominent and included increased IL1RL1 (IL33 receptor) and EMR1&3 and decreased CRISP2&3. A down-regulated PDGFB-centric network involving several smooth muscle-associated genes was also implicated. Genes at 17q11.2, genes associated with alternative activation or smooth muscle, and the IL1RL1 gene were also differentially transcribed in AD. CONCLUSIONS/SIGNIFICANCE: Our data implicate several genes or gene sets in aCRSwNP and eosinophilic epithelial inflammation, some that likely act in the earlier stages of inflammation. The identified gene expression changes provide additional diagnostic and therapeutic targets for aCRSwNP and other eosinophilic epithelial diseases.


Subject(s)
Asthma/genetics , Dermatitis, Atopic/genetics , Nasal Polyps/metabolism , Nasal Polyps/pathology , Rhinitis/genetics , Sinusitis/genetics , Transcription, Genetic/genetics , Adolescent , Adult , Calcium-Binding Proteins , Cell Adhesion Molecules , Chemokine CCL11/genetics , Chemokine CCL2/genetics , Chemokine CCL22/genetics , Chemokine CCL8/genetics , Chemokines, CC/genetics , Glycoproteins/genetics , Humans , Immunohistochemistry , Interleukin-1 Receptor-Like 1 Protein , Membrane Glycoproteins/genetics , Middle Aged , Monocyte Chemoattractant Proteins/genetics , Mucins/genetics , Radioimmunoprecipitation Assay , Receptors, Cell Surface/genetics , Receptors, G-Protein-Coupled/genetics , Receptors, Peptide/genetics , Reverse Transcriptase Polymerase Chain Reaction , Salivary Proteins and Peptides/genetics , Seminal Plasma Proteins/genetics , Young Adult
4.
J Immunol ; 183(6): 4013-20, 2009 Sep 15.
Article in English | MEDLINE | ID: mdl-19717523

ABSTRACT

Eosinophil granule proteins are deposited in cutaneous lesions in many human diseases, but how these proteins contribute to pathophysiology is obscure. We injected eosinophil cationic protein (ECP or RNase 3), eosinophil-derived neurotoxin (EDN or RNase 2), eosinophil peroxidase (EPO), and major basic protein-1 (MBP1) intradermally into guinea pig and rabbit skin. ECP and EDN each induced distinct skin lesions at >or=2.5 microM that began at 2 days, peaking at approximately 7 days and persisting up to 6 wk. These lesions were ulcerated (ECP) or crusted (EDN) with marked cellular infiltration. EPO and MBP1 (10 microM) each produced perceptible induration and erythema with moderate cellular infiltration resolving within 2 wk. ECP and EDN localized to dermal cells within 2 days, whereas EPO and MBP1 remained extracellular. Overall, cellular localization and RNase activity of ECP and EDN were critical for lesion formation; differential glycosylation, net cationic charge, or RNase activity alone did not account for lesion formation. Ulcerated lesions from patients with the hypereosinophilic syndrome showed ECP and EDN deposition comparable to that in guinea pig skin. In conclusion, ECP and EDN disrupt skin integrity and cause inflammation. Their presence in ulcerative skin lesions may explain certain findings in human eosinophil-associated diseases.


Subject(s)
Eosinophil Granule Proteins/toxicity , Eosinophils/enzymology , Ribonucleases/toxicity , Skin Diseases/etiology , Animals , Eosinophil Cationic Protein/administration & dosage , Eosinophil Cationic Protein/toxicity , Eosinophil Granule Proteins/administration & dosage , Eosinophil Major Basic Protein/administration & dosage , Eosinophil Major Basic Protein/toxicity , Eosinophil Peroxidase/administration & dosage , Eosinophil Peroxidase/toxicity , Eosinophil-Derived Neurotoxin/administration & dosage , Eosinophil-Derived Neurotoxin/toxicity , Eosinophilia/pathology , Guinea Pigs , Humans , Rabbits , Ribonucleases/administration & dosage , Skin Diseases/pathology , Ulcer/etiology
5.
Int Arch Allergy Immunol ; 149(2): 119-26, 2009.
Article in English | MEDLINE | ID: mdl-19127068

ABSTRACT

BACKGROUND: Pimecrolimus is a calcineurin inhibitor that inhibits T cell and mast cell activation and effectively treats atopic dermatitis. However, its effects on eosinophils, a cell type implicated in allergic disease pathology, are unknown. Therefore, we examined the effects of pimecrolimus on eosinophil superoxide anion production, degranulation and survival. METHODS: Purified eosinophils from normal or atopic donors were incubated with serial dilutions of pimecrolimus (microM to nM) and then stimulated with platelet activating factor (PAF), interleukin 5 (IL5), secretory immunoglobulin A (sIgA) or Alternaria alternata (Alt) fungus extract. Eosinophil activation was monitored by cytochrome c reduction resulting from superoxide anion production and by a 2-site immunoassay for eosinophil-derived neurotoxin (EDN) in cellular supernatants, as a marker of degranulation. Eosinophil survival was measured by propidium iodide exclusion using flow cytometry after 4 days in culture. RESULTS: Normal and atopic eosinophil superoxide anion production induced by PAF, and associated with increased intracellular calcium, was inhibited up to 37% with 1 microM pimecrolimus. However, superoxide anion production induced by IL5 and sIgA was not consistently inhibited. EDN release, which ultimately depends on calcium, was inhibited about 30% with PAF, IL5 and sIgA stimulation for normal and atopic donor eosinophils. Furthermore, calcium-dependent Alt-induced EDN release was inhibited up to 49% with nanomolar pimecrolimus. Finally, increased eosinophil survival promoted by IL5 and sIgA was not influenced by pimecrolimus. CONCLUSION: Pimecrolimus moderately inhibits eosinophil superoxide anion production and EDN release associated with calcium mobilization, which may contribute to its efficacy in treating atopic dermatitis.


Subject(s)
Calcineurin Inhibitors , Cell Degranulation/drug effects , Eosinophil-Derived Neurotoxin/immunology , Eosinophils/drug effects , Eosinophils/immunology , Tacrolimus/analogs & derivatives , Calcium/immunology , Calcium/metabolism , Cell Degranulation/immunology , Cell Survival/drug effects , Cell Survival/immunology , Cells, Cultured , Eosinophil-Derived Neurotoxin/analysis , Eosinophils/metabolism , Humans , Immunoglobulin A, Secretory/pharmacology , Interleukin-5/pharmacology , Platelet Activating Factor/pharmacology , Superoxides/analysis , Superoxides/immunology , Tacrolimus/pharmacology
6.
J Sep Sci ; 32(1): 44-56, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19051193

ABSTRACT

Allergic rhinitis (AR), chronic rhinosinusitis (CRS), and asthma are prevalent airway diseases that can have a substantial impact on a patient's quality of life. MS analyses of biological fluids can effectively screen for proteins associated with disease processes, however, initial detection of diagnostic proteins is difficult due to protein complexity and dynamic range. To enhance the detection of lower abundance proteins, intact nasal lavage fluid (NLF) proteins from nonpolypoid AR and from asthmatic CRS patients were extensively fractionated prior to LC/MS/MS analysis. Pooled NLF samples were processed to remove low molecular weight molecules and high abundance plasma proteins. Anion exchange (AX) chromatography followed by RP-LC further separated the remaining intact NLF proteins. The resulting fractions were digested with trypsin and the peptides analyzed by LC/MS/MS. Spectra were searched with MASCOT, SEQUEST, and X!Tandem to obtain peptide identifications and subsequently analyzed by Scaffold software to identify parent proteins with at least 99% confidence. The 197 identified proteins are compared to those previously cited in the literature and the workflow evaluated to determine the usefulness for the detection of lower abundance proteins. This is the first extensive list of NLF proteins generated from CRS patients with coexisting asthma.


Subject(s)
Asthma , Nasal Lavage Fluid/chemistry , Proteins/analysis , Rhinitis , Sinusitis , Adult , Asthma/diagnosis , Chromatography, Liquid , Chronic Disease , Female , Humans , Male , Middle Aged , Reproducibility of Results , Rhinitis/diagnosis , Sensitivity and Specificity , Sinusitis/diagnosis , Tandem Mass Spectrometry , Time Factors
7.
Exp Dermatol ; 16(1): 28-36, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17181634

ABSTRACT

Atopic dermatitis (AD) is a common pruritic dermatitis with macroscopically non-lesional skin that is often abnormal. Therefore, we used high-density oligonucleotide arrays to identify cutaneous gene transcription changes associated with early AD inflammation as potential disease control targets. Skin biopsy specimens analysed included normal skin from five healthy non-atopic adults and both minimally lesional skin and nearby or contralateral non-lesional skin from six adult AD patients. Data were analysed on an individual gene basis and to identify biologically relevant gene networks. Transcription levels of selected genes were also analysed by quantitative PCR. Differential transcription occurring early in AD skin was indicated for (i) individual genes such as C-C chemokine ligand (CCL)18, CCL13, and interferon-alpha2 (IFNalpha2), (ii) genes associated with peroxisome proliferator-activated receptor (PPAR)alpha- and PPARgamma-regulated transcription, and possibly for (iii) immunoglobulin J-chain and heavy chain isotype transcripts. These data suggest that local changes in immunoglobulin-associated transcription may favour IgE over secretory immunoglobulin (multimeric IgM and IgA) expression in AD skin. Decreased PPAR activity appears common to both AD and psoriasis, and reduced cutaneous IFNalpha2 transcription also appears characteristic of AD. Identification of these genes and pathways will direct future research towards controlling AD.


Subject(s)
Dermatitis, Atopic/genetics , Dermatitis, Atopic/metabolism , Skin/metabolism , Transcription, Genetic/genetics , Adult , Biopsy , Case-Control Studies , Chemokines, CC/genetics , Chemokines, CC/metabolism , Dermatitis, Atopic/pathology , Female , Gene Expression Regulation , Humans , Immunoglobulin E/genetics , Immunoglobulin E/metabolism , Interferon-alpha/genetics , Interferon-alpha/metabolism , Male , Monocyte Chemoattractant Proteins/genetics , Monocyte Chemoattractant Proteins/metabolism , Oligonucleotide Array Sequence Analysis , PPAR alpha/genetics , PPAR alpha/metabolism , PPAR gamma/genetics , PPAR gamma/metabolism , Skin/pathology
8.
J Immunol ; 177(10): 7340-5, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-17082653

ABSTRACT

Human eosinophil granule major basic protein (MBP1) is an exceedingly basic (isoelectric point >11) 14-kDa protein, comprising the core of the secondary eosinophil granule. Recently, a less cationic homolog of MBP, termed MBPH or simply, MBP2, has been discovered. We prepared a panel of mAbs to MBP2 and used these Abs to localize and quantitate this molecule in leukocytes and biological fluids. Specific mAbs for MBP2 were selected using slot-blot analyses and used in a two-site immunoassay, Western blotting, and immunofluorescence microscopy. The sensitivity of the immunoassay was markedly improved by reduction and alkylation of MBP2. MBP1 is more abundant than MBP2 in lysates of eosinophils and their granules, as judged by immunoassay and Western blotting. By immunofluorescence, MBP1 is present in eosinophils, basophils, and a human mast cell line (HMC1), whereas MBP2 is only detected in eosinophils. Neither MBP1 nor MBP2 could be detected in any other peripheral blood leukocyte. MBP2 levels measured in plasma and serum were essentially identical. In contrast to past measurements for MBP1, MBP2 was not detected above normal levels in sera from pregnant donors. However, measurement of serum MBP2 discriminated patients with elevated eosinophils from normal subjects, and MBP2 was also detectable in other biological specimens, such as bronchoalveolar lavage, sputum, and stool. These results indicate that MBP2 is present only in eosinophils and that it may be a useful biomarker for eosinophil-associated diseases.


Subject(s)
Eosinophils/chemistry , Proteoglycans/blood , Antibodies, Monoclonal/metabolism , Antibody Specificity , Biomarkers/blood , Biomarkers/chemistry , Biomarkers/urine , Blood Proteins/immunology , Blood Proteins/isolation & purification , Blood Proteins/urine , Eosinophil Major Basic Protein , Eosinophilia/blood , Feces/chemistry , Female , Humans , Immunoassay , Pregnancy , Pregnancy Proteins/blood , Pregnancy Proteins/urine , Proteoglycans/immunology , Proteoglycans/isolation & purification , Proteoglycans/urine , Structural Homology, Protein
9.
J Allergy Clin Immunol ; 117(3): 626-34, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16522463

ABSTRACT

BACKGROUND: Basophils possess characteristics of both mast cells and eosinophils, and all 3 cell types often are found together, particularly during allergic reactions. A mAb (J175-7D4) generated against the recombinant pro-form of human eosinophil granule major basic protein 1 (rproMBP1) appeared to stain only basophils in tissue specimens. OBJECTIVE: We investigated J175-7D4 to characterize its specificity for basophils. METHODS: Fluid-phase immunoprecipitation, Western blotting, and immunocytochemistry and immunohistochemistry were used to establish the specificity of J175-7D4. RESULTS: First, J175-7D4 binds to various glycosylated and proteolytically processed forms of rproMBP1, but not to major basic protein. Second, cells transfected with the rproMBP1 gene and human placental tissue (known to express the pro-form of major basic protein 1 [proMBP1]) stain specifically with J175-7D4. In contrast, although mature eosinophils contain substantial major basic protein, they lack proMBP1 and do not stain. Neutrophils, lymphocytes, monocytes, and skin mast cells also are not stained. However, blood basophils are stained by J175-7D4, anti-IgE, Wright-Giemsa (metachromatically), and a previously characterized basophil-specific mAb, 2D7. Finally, formaldehyde-fixed, paraffin-embedded basophils are identically detected by J175-7D4 and 2D7, and J175-7D4 also recognizes putative basophils in formaldehyde-fixed, paraffin-embedded tissue specimens from inflammatory dermatoses, such as atopic dermatitis and delayed pressure urticaria. CONCLUSION: The J175-7D4 mAb recognizes proMBP1 as a novel marker for human basophils. J175-7D4 should prove useful for characterizing basophil involvement in human health and disease.


Subject(s)
Antibodies, Monoclonal/immunology , Basophils/immunology , Eosinophil Major Basic Protein/biosynthesis , Immunoproteins/biosynthesis , Protein Precursors/biosynthesis , Basophils/metabolism , Biomarkers , Eosinophil Major Basic Protein/immunology , Humans
10.
J Immunol Methods ; 307(1-2): 54-61, 2005 Dec 20.
Article in English | MEDLINE | ID: mdl-16257006

ABSTRACT

Eosinophil granules contain several toxic cationic proteins that contribute to the pathophysiology of allergic diseases. These include eosinophil peroxidase, two ribonucleases, and two forms of the major basic protein (MBP). Extraction of eosinophil granules by exposure to acid solution and fractionation on Sephadex G-50 characteristically yields a distinctive profile of three discrete peaks, and these proteins are usually recovered in good quantities, except for the eosinophil major basic protein homolog (MBP2). We investigated the effect of multiple granule extractions by dilute HCl on the recovery of granule proteins. Isolated granules were repetitively extracted, up to 31 times, in 0.01 M HCl, and the extracts fractionated on Sephadex G-50. Whereas initial extracts yielded the characteristic three-peak fractionation pattern, later extracts yielded four discrete peaks. Characterization of the novel fourth peak showed that it contained MBP2. These results indicate that repetitive extraction of eosinophil granules yields an increased amount of all granule proteins, and that MBP2 can now be recovered in good quantities and in a relatively pure form.


Subject(s)
Eosinophil Granule Proteins/isolation & purification , Eosinophils/chemistry , Blood Proteins/isolation & purification , Cell Fractionation , Cell Separation , Chromatography, Gel , Cytoplasmic Granules/chemistry , Electrophoresis, Polyacrylamide Gel , Eosinophil Cationic Protein/isolation & purification , Eosinophil Major Basic Protein , Eosinophil Peroxidase/isolation & purification , Eosinophil-Derived Neurotoxin/isolation & purification , Eosinophilia/blood , Eosinophils/cytology , Flavins/chemistry , Humans , Immunoassay , Luminescent Measurements , Proteoglycans/isolation & purification , Spectrometry, Fluorescence
11.
J Allergy Clin Immunol ; 112(5): 988-94, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14610493

ABSTRACT

BACKGROUND: Eosinophil granule proteins, including eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil peroxidase (EPO), and major basic protein (MBP), are prominently deposited in skin in several cutaneous disorders and likely contribute to disease pathology. OBJECTIVE: We sought to determine the limit of detection, persistence, and vasopermeabilization activity of the eosinophil granule proteins in skin. METHODS: The eosinophil granule proteins were injected intradermally. Their minimum detectable concentrations in human surgical waste skin and their persistence in guinea pig skin were determined by indirect immunofluorescence. Vasopermeabilization activity in the guinea pig without and with H1 antihistamine (pyrilamine maleate) pretreatment was assessed by extrusion of Evans blue dye-treated plasma. RESULTS: The lowest detectable cutaneous concentrations were 0.05 micromol/L EPO, 0.1 micromol/L MBP, 0.25 micromol/L ECP, and 1 micromol/L EDN. Granule proteins persisted in guinea pig skin in vivo for 1 week (EPO), 2 weeks (ECP), 2.5 weeks (EDN), and 6 weeks (MBP). Each of the eosinophil granule proteins increased cutaneous vasopermeability in a concentration-dependent manner. The potency of vasopermeabilization induced by each granule protein was comparable with that of histamine. Pyrilamine maleate pretreatment of guinea pigs did not alter increased vasopermeability induced by ECP and EDN but significantly inhibited that induced by EPO and MBP. CONCLUSIONS: Micromolar concentrations of eosinophil granule proteins are often deposited in skin in eosinophil-associated cutaneous disorders such as atopic dermatitis. These pathophysiologically relevant concentrations of eosinophil granule proteins cause increased cutaneous vasopermeability (both by means of histamine-independent and histamine-dependent mechanisms) and might alter cutaneous function for days to weeks.


Subject(s)
Blood Proteins , Blood Proteins/metabolism , Peroxidases/metabolism , Ribonucleases , Ribonucleases/metabolism , Skin/metabolism , Animals , Blood Proteins/pharmacology , Capillary Permeability/drug effects , Eosinophil Granule Proteins , Eosinophil Peroxidase , Eosinophil-Derived Neurotoxin , Fluorescent Antibody Technique, Indirect , Guinea Pigs , Histamine H1 Antagonists/pharmacology , Humans , Osmolar Concentration , Peroxidases/pharmacology , Pyrilamine/pharmacology , Ribonucleases/pharmacology , Skin/blood supply , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...